A single-arm, open-label Phase IIa study to evaluate the efficacy and safety of copanlisib monotherapy in patients with relapsed or refractory mantle cell lymphoma (MCL), who failed ibrutinib treatment or were unable to tolerate ibrutinib - Regional Cancer Care Associates LLC

Clinical Trials

A single-arm, open-label Phase IIa study to evaluate the efficacy and safety of copanlisib monotherapy in patients with relapsed or refractory mantle cell lymphoma (MCL), who failed ibrutinib treatment or were unable to tolerate ibrutinib

Type of Cancer
Lymphoma
Locations
Hackensack
Sponsor
Bayer
Protocol Number
Bayer 17120
Cancer Diagnosis
To Learn More Call
201-510-0910